文献速递炎症性肠病

ATF4缺陷通过减少谷氨酰胺摄取和抗菌肽表达促进小鼠肠道炎症

ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
PubMed 文献 · Gastroenterology · 2018-11-16

研究探讨ATF4在炎症性肠病(IBD)患者和结肠炎小鼠中的变化。在活动性克罗恩病(CD)和溃疡性结肠炎(UC)患者炎症黏膜中ATF4水平显著降低;小鼠肠上皮细胞特异性ATF4缺陷导致自发性小肠结肠炎、DSS结肠炎加重、血清谷氨酰胺降低及抗菌肽表达减少,而谷氨酰胺补充或DEFA1注射可逆转部分改变。ATF4可能成为IBD治疗靶点。

要点

  • 活动性CD和UC患者炎症黏膜中ATF4水平显著降低。
  • 肠上皮细胞ATF4缺陷小鼠发生自发性小肠结肠炎,DSS结肠炎加重。
  • ATF4缺陷减少谷氨酰胺摄取和抗菌肽表达,谷氨酰胺补充可逆转菌群改变。

核心结论

  • 活动性CD或UC患者炎症肠道黏膜中ATF4水平降低。
  • 小鼠中ATF4缺陷通过降低Slc1a5转录减少肠上皮细胞谷氨酰胺摄取和抗菌肽表达。
  • ATF4可能成为IBD的治疗靶点。

研究设计与样本

  • 获取21例活动性CD、22例活动性UC和38例无IBD对照的结肠炎症和/或非炎症区域活检标本,以及19例活动性CD和8例无IBD对照的回肠标本。
  • 使用肠上皮细胞特异性Atf4敲除小鼠(Atf4ΔIEC小鼠)和Atf4-floxed对照小鼠,给予葡聚糖硫酸钠(DSS)诱导结肠炎。
  • 部分小鼠接受重组防御素α1(DEFA1)注射以及饮水中补充L-丙氨酰-谷氨酰胺或谷氨酰胺。
  • 使用小干扰RNA在IEC-18细胞中敲低ATF4,并通过16S核糖体DNA测序分析小鼠回肠粪便微生物组。

主要发现

  • 活动性CD或UC患者炎症肠道黏膜中ATF4水平显著低于非炎症区域或无IBD对照的肠道黏膜。
  • 结肠炎小鼠结肠上皮中ATF4较无结肠炎小鼠降低。
  • Atf4ΔIEC小鼠发生自发性小肠结肠炎,且DSS给药后结肠炎严重程度高于对照小鼠。
  • Atf4ΔIEC小鼠血清谷氨酰胺水平降低,回肠潘氏细胞中Defa1、Defa4、Defa5、Camp和Lyz1等抗菌肽水平降低。
  • Atf4ΔIEC小鼠回肠微生物组较对照小鼠发生改变,谷氨酰胺给药可逆转这些改变;DEFA1注射降低Atf4ΔIEC小鼠自发性肠炎和DSS诱导结肠炎的严重程度。

关键数值与推荐

  • ATF4直接调控谷氨酰胺转运体溶质载体家族1成员5(SLC1A5)在细胞系中的表达。
  • IEC-18或原代IEC细胞中过表达SLC1A5增加谷氨酰胺摄取和抗菌肽表达。
  • IEC-18细胞中敲低ATF4增加炎性细胞因子表达,而在敲低细胞中过表达SLC1A5降低细胞因子表达。
  • CD和UC患者炎症肠道黏膜中SLC1A5水平降低,并与ATF4水平相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Activating transcription factor 4 (ATF4) regulates genes involved in the inflammatory response, amino acid metabolism, autophagy, and endoplasmic reticulum stress. We investigated whether its activity is altered in patients with inflammatory bowel diseases (IBDs) and mice with enterocolitis. METHODS: We obtained biopsy samples during endoscopy from inflamed and/or uninflamed regions of the colon from 21 patients with active Crohn's disease (CD), 22 patients with active ulcerative colitis (UC), and 38 control individuals without IBD and of the ileum from 19 patients with active CD and 8 individuals without IBD in China. Mice with disruption of Atf4 specifically in intestinal epithelial cells (Atf4ΔIEC mice) and Atf4-floxed mice (controls) were given dextran sodium sulfate (DSS) to induce colitis. Some mice were given injections of recombinant defensin α1 (DEFA1) and supplementation of l-alanyl-glutamine or glutamine in drinking water. Human and mouse ileal and colon tissues were analyzed by quantitative real-time polymerase chain reaction, immunoblots, and immunohistochemistry. Serum and intestinal epithelial cell (IEC) amino acids were measured by high-performance liquid chromatography-tandem mass spectrometry. Levels of ATF4 were knocked down in IEC-18 cells with small interfering RNAs. Microbiomes were analyzed in ileal feces from mice by using 16S ribosomal DNA sequencing. RESULTS: Levels of ATF4 were significantly decreased in inflamed intestinal mucosa from patients with active CD or active UC compared with those from uninflamed regions or intestinal mucosa from control individuals. ATF4 was also decreased in colonic epithelia from mice with colitis vs mice without colitis. Atf4ΔIEC mice developed spontaneous enterocolitis and colitis of greater severity than control mice after administration of DSS. Atf4ΔIEC mice had decreased serum levels of glutamine and reduced levels of antimicrobial peptides, such as Defa1, Defa4, Defa5, Camp, and Lyz1, in ileal Paneth cells. Atf4ΔIEC mice had alterations in ileal microbiomes compared with control mice; these changes were reversed by administration of glutamine. Injections of DEFA1 reduced the severity of spontaneous enteritis and DSS-induced colitis in Atf4ΔIEC mice. We found that expression of solute carrier family 1 member 5 (SLC1A5), a glutamine transporter, was directly regulated by ATF4 in cell lines. Overexpression of SLC1A5 in IEC-18 or primary IEC cells increased glutamine uptake and expression of antimicrobial peptides. Knockdown of ATF4 in IEC-18 cells increased expression of inflammatory cytokines, whereas overexpression of SLC1A5 in the knockdown cells reduced cytokine expression. Levels of SLC1A5 were decreased in inflamed intestinal mucosa of patients with CD and UC and correlated with levels of ATF4. CONCLUSIONS: Levels of ATF4 are decreased in inflamed intestinal mucosa from patients with active CD or UC. In mice, ATF4 deficiency reduces glutamine uptake by intestinal epithelial cells and expression of antimicrobial peptides by decreasing transcription of Slc1a5. ATF4 might therefore be a target for the treatment of IBD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hu X, Deng J, Yu T, et al. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides. Gastroenterology. 2018. PMID: 30452920. doi:10.1053/j.gastro.2018.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。